<VariationArchive VariationID="2424611" VariationName="NC_000003.11:g.(?_11067270)_(11069305_?)del" VariationType="Deletion" Accession="VCV002424611" Version="4" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-07-29" DateCreated="2023-02-13" MostRecentSubmission="2024-06-09">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1949687" VariationID="2424611">
      <GeneList>
        <Gene Symbol="SLC6A1" FullName="solute carrier family 6 member 1" GeneID="6529" HGNC_ID="HGNC:11042" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>3p25.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="10992748" stop="11039247" display_start="10992748" display_stop="11039247" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="11034419" stop="11080934" display_start="11034419" display_stop="11080934" Strand="+" />
          </Location>
          <OMIM>137165</OMIM>
          <Haploinsufficiency last_evaluated="2019-09-25" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SLC6A1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2019-09-25" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SLC6A1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NC_000003.11:g.(?_11067270)_(11069305_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>3p25.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" innerStart="11067270" innerStop="11069305" display_start="11067270" display_stop="11069305" variantLength="2036" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.11" sequenceAccession="NC_000003" sequenceVersion="11" change="g.(?_11067270)_(11069305_?)del" Assembly="GRCh37">
            <Expression>NC_000003.11:g.(?_11067270)_(11069305_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000003.11:g.(?_11067270)_(11069305_?)del AND Myoclonic-atonic epilepsy" Accession="RCV004565769" Version="1">
        <ClassifiedConditionList TraitSetID="92306">
          <ClassifiedCondition DB="MedGen" ID="CN231318">Myoclonic-atonic epilepsy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-05-15" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-05-15" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-02-13" MostRecentSubmission="2024-06-09">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">25865495</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="92306" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="33535" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Myoclonic-atonic epilepsy</ElementValue>
                <XRef ID="MONDO:0014633" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MAE</ElementValue>
                <XRef Type="MIM" ID="616421" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16108" />
                <XRef ID="16108" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">36780407</ID>
                <ID Source="BookShelf">NBK589173</ID>
              </Citation>
              <XRef ID="1942" DB="Orphanet" />
              <XRef ID="CN231318" DB="MedGen" />
              <XRef ID="MONDO:0014633" DB="MONDO" />
              <XRef Type="MIM" ID="616421" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7073464" SubmissionDate="2024-06-04" DateLastUpdated="2024-06-09" DateCreated="2023-02-13">
        <ClinVarSubmissionID localKey="NM_003042.3_3_Deletion (exons 9-10)_11067269_11069305|MedGen:C4085238" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003791275" DateUpdated="2024-06-09" DateCreated="2023-02-13" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-05-15">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">25865495</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with SLC6A1-related conditions. This variant is a gross deletion of the genomic region encompassing exon(s) 9-10 of the SLC6A1 gene. This deletion is out-of-frame, and is expected to create a premature termination codon and result in an absent or disrupted protein product. Loss-of-function variants in SLC6A1 are known to be pathogenic (PMID: 25865495).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC6A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000003.11:g.(?_11067270)_(11069305_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C4085238" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12699154</SubmissionName>
          <SubmissionName>SUB14505679</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7073464" TraitType="Disease" MappingType="XRef" MappingValue="C4085238" MappingRef="MedGen">
        <MedGen CUI="CN231318" Name="Myoclonic-atonic epilepsy" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

